Coherus Oncology, Inc. (CHRS) quarterly cash flow statement — complete operating, investing & financing history
Coherus Oncology, Inc. (CHRS) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -119.98M | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.94M | -54.3M | -38.91M | -68.73M | -99.95M | -37.09M | -50.04M | -54.05M | -52.32M | 13.71M |
| Operating CF Margin % | -838.58% | -470.24% | -154.66% | -400.48% | -454.77% | -339.86% | 52.84% | -87.63% | 91.93% | -2026.26% | -14.14% | -72.82% | -66.28% | -211.9% | -220.39% | -81.65% | -83.19% | -89.9% | -71.31% | 16.62% |
| Operating CF Growth % | -157.28% | -124.14% | -168.92% | 25.28% | -178.07% | 44.78% | 321.13% | -14.21% | 253.5% | 31.96% | 87.06% | -46.4% | 22.23% | -27.18% | -91.03% | -370.51% | -26515.43% | -4053.55% | -257.96% | -71.05% |
| Net Income | -58.96M | -37.94M | 241.2M | -35.53M | 297.77M | -56.57M | -50.7M | -10.75M | -54.85M | 102.88M | -79.65M | -39.64M | -42.87M | -75.73M | -58.87M | -86.65M | -50.15M | -96.08M | -45.73M | -38.53M |
| Depreciation & Amortization | 862K | 881K | 896K | 966K | 1.02M | 1.05M | 1.03M | 1.55M | 1.19M | 1.51M | 1.06M | 899K | 880K | 949K | 1.05M | 900K | 900K | 4.46M | 1.43M | 892K |
| Stock-Based Compensation | 4.97M | 2.38M | 10.79M | 3.39M | 5.42M | 5.37M | 6.38M | 6.87M | 0 | 7.32M | 10.8M | 9.95M | 10.08M | 12.28M | 11.73M | 0 | 0 | 12.88M | 0 | 11.94M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 874K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -10.45M | 468K | -259.81M | -5.77M | -327.18M | 13.47M | 17.35M | 1.85M | 39.13M | -147.09M | 48.49M | 1.24M | -774K | 3.11M | 754K | 39.97M | 15.43M | 46.57M | 12.59M | 7.09M |
| Working Capital Changes | -56.4M | -23.68M | -12.79M | -9.39M | -23.65M | 10.86M | 54.54M | -61.53M | 74.26M | -11.38M | 6.37M | -27.62M | -6.23M | -9.35M | -54.61M | 8.69M | -16.22M | -21.87M | -20.61M | 32.32M |
| Change in Receivables | 3.94M | -4.28M | 106.16M | -4.27M | 55.27M | 50.89M | 56.33M | 7.81M | 76.64M | 8.58M | -44.06M | -75.28M | -39.88M | 8.53M | -18.8M | 24.52M | 1.34M | 5.99M | 13.34M | 5.48M |
| Change in Inventory | -10.88M | -11.31M | -18.47M | 2.48M | 3.77M | -22.24M | -6.45M | -6.94M | -7.1M | -11.46M | -11.79M | -19.23M | -13.04M | -2.67M | -9.79M | -23.35M | -11.24M | -2.96M | -9.19M | 6.8M |
| Change in Payables | 4.25M | 2.56M | 833K | -15.3M | -12.21M | 13.04M | 6.34M | -50.36M | 39.46M | 616K | -785K | 6.76M | 6.05M | 11.74M | 1.6M | -7.57M | -3.33M | 0 | -29.62M | 31.27M |
| Cash from Investing | 60.29M | 30.66M | -2.84M | -67.23M | 462.64M | -17.49M | -542K | 444K | 27.66M | 202.76M | 35.2M | 50.55M | 41.37M | 17.53M | -129.9M | -457K | -880K | -35.62M | 107.49M | 15.99M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34K | 0 | -100K | -152K | -87K | -457K | -880K | -615K | -468K | -261K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | 0.04% | - | 0.17% | 0.47% | 0.19% | 1.01% | 1.46% | 1.02% | 0.64% | 0.32% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76K | 151K | 440K | 178K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.1M | -1.09M | -8.39M | -27K | 483.36M | -17.49M | -542K | 444K | 27.66M | 187.88M | -1.05M | 7M | 0 | 178K | -2.43M | 0 | 0 | -35M | 0 | 0 |
| Cash from Financing | 53.73M | 53.59M | 8.08M | 2K | -281.52M | -264K | 231K | -167K | -187.93M | 887K | 366K | 11.11M | 54.33M | 3.8M | 6.59M | 48.87M | 721K | -1.85M | 1.49M | 1.1M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -233.19M | 0 | -223.41M | 223.27M | -223.27M | 0 | 0 | 0 | 0 | 0 | 0 | 49.49M | 0 | 440K | -672K | 0 |
| Equity Issued (Net) | 53.65M | 53.65M | 8.06M | -3K | 188K | -264K | 1.7M | -1.46M | 633K | 1.51M | 891K | 11.44M | 54.9M | 6.83M | 6.36M | 79K | 1.66M | -2.66M | 1.69M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -3K | 0 | -264K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.66M | 0 | 0 |
| Other Financing | 84K | -60K | 22K | 5K | -48.53M | 0 | 221.94M | -221.98M | 34.71M | -620K | -525K | -332K | -577K | -3.03M | 235K | -701K | -942K | 363K | 469K | 1.1M |
| Net Change in Cash | -5.96M | 26.36M | -14.47M | -113.54M | 134.48M | -43.58M | 28.3M | -61.74M | -100.53M | 156.88M | 22.18M | 7.35M | 56.77M | -47.4M | -223.26M | 11.32M | -50.2M | -91.52M | 56.66M | 30.8M |
| Free Cash Flow | -119.98M | -57.89M | -19.72M | -46.34M | -46.63M | -25.83M | 28.61M | -62.02M | 59.73M | -46.77M | -12.97M | -54.3M | -39.02M | -68.88M | -100.04M | -37.55M | -50.92M | -54.66M | -52.79M | 13.45M |
| FCF Margin % | -838.58% | -470.24% | -154.66% | -400.48% | -454.77% | -339.86% | 52.84% | -87.63% | 91.93% | -2026.26% | -14.17% | -72.82% | -66.45% | -212.37% | -220.59% | -82.66% | -84.65% | -90.93% | -71.95% | 16.3% |
| FCF Growth % | -157.28% | -124.14% | -168.92% | 25.28% | -178.07% | 44.78% | 320.55% | -14.21% | 253.11% | 32.11% | 87.03% | -44.62% | 23.38% | -26.02% | -89.51% | -379.15% | -8343.95% | -4573% | -264.09% | -70.27% |
| FCF per Share | -0.77 | -0.42 | -0.16 | -0.40 | -0.40 | -0.22 | 0.25 | -0.54 | 0.52 | -0.37 | -0.12 | -0.56 | -0.45 | -0.87 | -1.28 | -0.48 | -0.66 | -0.71 | -0.69 | 0.17 |
| FCF Conversion (FCF/Net Income) | 5.82x | 1.53x | 0.53x | 1.32x | 1.13x | 0.46x | -0.56x | 5.77x | -4.62x | -0.45x | 0.16x | 1.37x | 0.91x | 0.91x | 1.70x | 0.43x | 1.00x | 0.56x | 1.14x | -0.36x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 25.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |